These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 27135485

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM, Loftus EV, Sandborn WJ, Bryant SC, Smyrk TC.
    Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and RUNX3 methylation.
    Garrity-Park M, Loftus EV, Sandborn WJ, Smyrk TC.
    Inflamm Bowel Dis; 2012 Feb; 18(2):275-83. PubMed ID: 21425209
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC.
    Scarpa M, Scarpa M, Castagliuolo I, Erroi F, Kotsafti A, Basato S, Brun P, D'Incà R, Rugge M, Angriman I, Castoro C.
    Oncotarget; 2016 Mar 01; 7(9):10322-31. PubMed ID: 26862732
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. DNA methylation patterns in ulcerative colitis-associated cancer: a systematic review.
    Emmett RA, Davidson KL, Gould NJ, Arasaradnam RP.
    Epigenomics; 2017 Jul 01; 9(7):1029-1042. PubMed ID: 28621161
    [Abstract] [Full Text] [Related]

  • 10. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
    Hanaoka M, Ishikawa T, Ishiguro M, Tokura M, Yamauchi S, Kikuchi A, Uetake H, Yasuno M, Kawano T.
    J Gastroenterol; 2018 May 01; 53(5):631-641. PubMed ID: 28884228
    [Abstract] [Full Text] [Related]

  • 11. Prediction of colorectal neoplasia by quantitative methylation analysis of estrogen receptor gene in nonneoplastic epithelium from patients with ulcerative colitis.
    Tominaga K, Fujii S, Mukawa K, Fujita M, Ichikawa K, Tomita S, Imai Y, Kanke K, Ono Y, Terano A, Hiraishi H, Fujimori T.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8880-5. PubMed ID: 16361578
    [Abstract] [Full Text] [Related]

  • 12. Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias.
    Konishi K, Shen L, Wang S, Meltzer SJ, Harpaz N, Issa JP.
    Gastroenterology; 2007 Apr 15; 132(4):1254-60. PubMed ID: 17408633
    [Abstract] [Full Text] [Related]

  • 13. Discovery and Validation of Methylation Biomarkers for Ulcerative Colitis Associated Neoplasia.
    Beggs AD, James J, Caldwell G, Prout T, Dilworth MP, Taniere P, Iqbal T, Morton DG, Matthews G.
    Inflamm Bowel Dis; 2018 Jun 08; 24(7):1503-1509. PubMed ID: 29762666
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Genomic biomarkers to improve ulcerative colitis neoplasia surveillance.
    Bronner MP, O'Sullivan JN, Rabinovitch PS, Crispin DA, Chen L, Emond MJ, Rubin CE, Brentnall TA.
    Am J Pathol; 2008 Dec 08; 173(6):1853-60. PubMed ID: 18988798
    [Abstract] [Full Text] [Related]

  • 16. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT, Rothe JA, Hetzel JT, Cohen RD, Hanauer SB.
    Gastrointest Endosc; 2007 Jun 08; 65(7):998-1004. PubMed ID: 17451704
    [Abstract] [Full Text] [Related]

  • 17. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
    Venkatesh PG, Jegadeesan R, Gutierrez NG, Sanaka MR, Navaneethan U.
    J Crohns Colitis; 2013 Dec 08; 7(12):968-73. PubMed ID: 23433613
    [Abstract] [Full Text] [Related]

  • 18. Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis.
    Li Y, de Haar C, Chen M, Deuring J, Gerrits MM, Smits R, Xia B, Kuipers EJ, van der Woude CJ.
    Gut; 2010 Feb 08; 59(2):227-35. PubMed ID: 19926618
    [Abstract] [Full Text] [Related]

  • 19. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
    Navaneethan U, Jegadeesan R, Gutierrez NG, Venkatesh PG, Hammel JP, Shen B, Kiran RP.
    J Crohns Colitis; 2013 Dec 08; 7(12):e684-91. PubMed ID: 23916526
    [Abstract] [Full Text] [Related]

  • 20. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
    Navaneethan U, Kochhar G, Venkatesh PG, Bennett AE, Rizk M, Shen B, Kiran RP.
    J Crohns Colitis; 2013 Dec 08; 7(12):974-81. PubMed ID: 23523416
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.